PASD1

Chr X

PAS domain containing repressor 1

Also known as: CT63, CT64, OXTES1

This gene encodes a protein that is thought to function as a transcription factor. The protein is a cancer-associated antigen that can stimulate autologous T-cell responses, and it is therefore considered to be a potential immunotherapeutic target for the treatment of various hematopoietic malignancies, including diffuse large B-cell lymphoma. [provided by RefSeq, May 2010]

0
Active trials
86
Pathogenic / LP
210
ClinVar variants
0
Pubs (1 yr)
-0.8
Missense Z
0.38
LOEUF
Clinical SummaryPASD1
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.82) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
86 Pathogenic / Likely Pathogenic· 102 VUS of 210 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.38LOEUF
pLI 0.823
Z-score 4.00
OE 0.18 (0.090.38)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
-0.81Z-score
OE missense 1.14 (1.041.25)
319 obs / 280.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.18 (0.090.38)
00.351.4
Missense OE1.14 (1.041.25)
00.61.4
Synonymous OE1.13
01.21.6
LoF obs/exp: 5 / 27.7Missense obs/exp: 319 / 280.7Syn Z: -1.05

ClinVar Variant Classifications

210 submitted variants in ClinVar

Classification Summary

Pathogenic84
Likely Pathogenic2
VUS102
Likely Benign21
Conflicting1
84
Pathogenic
2
Likely Pathogenic
102
VUS
21
Likely Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
84
0
84
Likely Pathogenic
0
0
2
0
2
VUS
0
99
3
0
102
Likely Benign
0
19
0
2
21
Benign
0
0
0
0
0
Conflicting
1
Total0118892210

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

PASD1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Analogue peptides for the immunotherapy of human acute myeloid leukemia.
Hofmann S et al.·Cancer Immunol Immunother
2015Review
Top 1 results · since 2015Search PubMed ↗